Loading…

Anthrylphosphonate and π-conjugated acid cocrystal as a Mycobacterium tuberculosis inhibitor: Role of P=O…H interactions

•Anthracenylphosphonate and π-conjugated acid cocrystal is with anti- MTB property.•The minimal inhibitory concentration (MIC) of 1.56 µg/mL is comparable with ethambutol.•The individual components phosphonate or acid are relatively inert.•An equimolar mixture of phosphonate and acid appears ineffec...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular structure 2021-10, Vol.1241, p.130642, Article 130642
Main Authors: Prusti, Banchhanidhi, Sivakrishna, Vagolu, Sriram, Dharmarajan, Chakravarty, Manab
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Anthracenylphosphonate and π-conjugated acid cocrystal is with anti- MTB property.•The minimal inhibitory concentration (MIC) of 1.56 µg/mL is comparable with ethambutol.•The individual components phosphonate or acid are relatively inert.•An equimolar mixture of phosphonate and acid appears ineffective.•P = O…H interactions in cocrystal and solution play a vital role in this distinction. There have been continuous efforts to develop a candidate to combat Mycobacterium tuberculosis (MTB). Versatile, organic functional groups are being proved to be effective against MTB. However, there is a significant need for better candidates. Research on pharmaceutical cocrystal has made substantial demand with the improved physical and chemical properties and was treated as a new drug. The typical anti-MTB drug isoniazid was cocrystallized with pharmaceutically approved acids to promote stability and solubility, but the anti-MTB effect after the enhanced properties are not being evaluated. Thus, the cocrystal-based drug concept towards anti-MTB treatment has a significant lack of maturity. Herein, we have identified biologically active anthranylphosphonate as a cocrystal form with its π-conjugated acid and established it as a candidate against MTB (in vitro) with an effective minimal inhibitory concentration (MIC) of 1.56 µg/mL. The individual components phosphonate and acid disclosed the MIC (µg/mL) of 12.5 and 6.25 against MTB. As a replacement of the stoichiometric 1:1 cocrystal, MIC value for a different 1:1 mixture of phosphonate and acid was determined, and the result was disappointing. Moreover, the cytotoxic effect was not acceptable for this distinct 1:1 mixture. Such an outcome is quite exciting for a cocrystal approach to fight against MTB. We found an essential role of strong P=O…H interactions that possibly exist only in cocrystal solution, not in the separate 1:1 mixture. The same is evidenced by single-crystal X-ray in the solid-state and 31P/1H NMR spectral shift in the solution state.
ISSN:0022-2860
1872-8014
DOI:10.1016/j.molstruc.2021.130642